Looking Ahead

This is a promising time for individuals who have been diagnosed with MS. Since the early 1990s, treatment options have gone from zero to five and more therapeutic agents are on their way. Among others, MS drugs under investigation include cancer-fighting drugs, antiviral medications, vaccines, bone marrow transplants, pregnancy-related hormones, cholesterol-fighting drugs, stem cells, and agents such as growth factors that may repair myelin. Regeneration, neuroprotection, and gene therapy are also being explored. At the time of this writing, Tysabri® (natalizumab) had been approved as a sixth drug treatment for MS, but was suspended due to adverse events.

For more information about MS research and treatments, please contact MSAA, which offers several other informative publications and a quarterly magazine, The Motivator, as well as the MSAA Lending Library.

MSAA may be contacted by calling (800) 532-7667, or by visiting MSAA's website at www.msaa.com.

Sources for more information include:

Consortium of Multiple Sclerosis Centers (CMSC)
CMSC/NARCOMS patient
registry: (800) 253-7884
www.mscare.org
www.narcoms.org

Multiple Sclerosis Foundation
(888) 673-6287
www.msfacts.org

National Multiple Sclerosis Society
(800) 344-4867
www.nmss.org

(Avonex) MS ActiveSource
(800) 456-2255
www.avonex.com

(Betaseron) MS Pathways
(800) 788-1467
www.mspathways.com

(Copaxone) Shared Solutions
(800) 887-8100
www.sharedsolutions.com

(Novantrone) MS LifeLines
(877) 447-3243
www.novantrone.com

(Rebif) MS LifeLines
(877) 447-3243
www.MSLifeLines.com

Back: Five Approved Long-Term Treatments for MS | Index | Next: References